Article
Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors.
Journal of immunology (Baltimore, Md. : 1950) - 1 Oct 2005
Krych-Goldberg Malgorzata, Hauhart Richard E, Porzukowiak Tina, Atkinson John P
Abstract excerpt
The extracellular domain of the complement receptor type 1 (CR1; CD35) consists entirely of 30 complement control protein repeats (CCPs). CR1 has two distinct functional sites, site 1 (CCPs 1-3) and two copies of site 2 (CCPs 8-10 and CCPs 15-17). In this report we further define the structural requirements for decay-accelerating activity (DAA) for the classical pathway (CP) C3 and C5 convertases and, using these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
